We are Nu10, focused on Data Engineering, AI, and GenAI to enhance businesses by automating complex processes, delivering personalized customer experiences, and providing actionable insights through advanced data analytics. Our mission is to enable our clients to drive efficiency, innovation, and informed decision-making.To further these goals, we have built Nu10 PrismAI, a platform for integrating multiple LLMs and AI/ML algorithms. Nu10 PrismAI facilitates the creation of custom analytics products, reducing time to market and leapfrogging traditional approaches to AI. Through this innovative platform, we empower our clients to achieve greater operational effectiveness and foster groundbreaking advancements.My personal current focus is on the Fintech and Healthtech space. We have implemented complex tech for SaMD managing data flow from chip to cloud in near real-time. Efficient Data Management, personalized treatment plans and predictive diagnostics have helped our clients to improve patient outcomes. --------------------------Prior to Nu10, I founded and built Manthan Research and Analytics, which got acquired by M3, and got rebranded to m360 Research. M3 is a $40bn+ Japanese Medical Information firm which is the youngest Nikkei 225 company.m360 Research provides solutions to support strategic decision making across the entire drug lifecycle from discovery to sales & marketing specifically market & business intelligence services. We built a highly engaged community of 300,000+ physicians in North America and were amongst the largest such community in Canada and the US. We specialized in using cutting edge advanced analytics techniques like NLP, unstructured data analytics, machine learning to drive actionable intelligence. Post acquisition, managed transition , navigated and grew m360 Research by more than 50% during the pandemic, before deciding to start afresh in the tech space in early 2021.Overall, I enjoy breaking new ground, building & scaling high performing teams ground up and create new solutions.